[Antibiotic therapy in severe infections caused by Pseudomonas aeruginosa]. 1990

J Torné Cachot

UI MeSH Term Description Entries
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D002442 Ceftazidime Semisynthetic, broad-spectrum antibacterial derived from CEPHALORIDINE and used especially for Pseudomonas and other gram-negative infections in debilitated patients. Ceftazidime Anhydrous,Ceftazidime Pentahydrate,Fortaz,Fortum,GR-20263,LY-139381,Pyridinium, 1-((7-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, pentahydrate, (6R-(6alpha,7beta(Z)))-,Tazidime,GR 20263,GR20263,LY 139381,LY139381
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Torné Cachot
September 1986, Presse medicale (Paris, France : 1983),
J Torné Cachot
November 1961, The Journal of the Indiana State Medical Association,
J Torné Cachot
January 1983, Reviews of infectious diseases,
J Torné Cachot
January 1999, Anesteziologiia i reanimatologiia,
J Torné Cachot
September 1998, Revista clinica espanola,
J Torné Cachot
January 1987, Antibiotics and chemotherapy,
J Torné Cachot
January 1970, Salud publica de Mexico,
J Torné Cachot
June 1971, Journal of chronic diseases,
J Torné Cachot
July 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
Copied contents to your clipboard!